The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness
- PMID: 2177360
The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness
Abstract
Using standard microelectrode techniques, the authors compared the effects of 15 to 125 microM concentrations of mexiletine, 31 to 500 microM concentrations of sotalol and 15 to 125 microM of mexiletine combined with 125 microM sotalol, on the beat-to-beat action potential duration and refractoriness of porcine papillary muscles and Purkinje fibres stimulated by 30 beat trains at a frequency of 1 Hz. Sotalol alone prolonged action potential duration and effective refractory period without altering their ratio. Mexiletine shortened action potential duration while prolonging refractoriness. When the two drugs were combined, action potential duration was shortened to the same extent as with mexiletine alone, but refractoriness, particularly in papillary muscle, was further prolonged. These changes suggest additive inhibition of the sodium window current by both drugs. Purkinje action potential duration was longest in the first beat of the train, while in papillary muscle, this beat was shortest. Exposure to either or both drugs eliminated the prolongation of duration of the first beat of the train in Purkinje fibre. Thus, the phenomenon of restitution, which prolongs the duration of the first beat after a long diastolic interval, appears also to be related to the sodium window current.
Similar articles
-
The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. I. Alteration of mexiletine-induced Vmax depression.Can J Cardiol. 1990 Nov;6(9):416-22. Can J Cardiol. 1990. PMID: 2177359
-
The cellular electropharmacology of mexiletine in papillary muscles of guinea pigs chronically treated with amiodarone.Can J Cardiol. 1992 Jan-Feb;8(1):69-77. Can J Cardiol. 1992. PMID: 1617514
-
Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.Br J Pharmacol. 1979 Sep;67(1):143-52. Br J Pharmacol. 1979. PMID: 497518 Free PMC article.
-
A comparison of the cellular electrophysiology of mexiletine and sotalol, singly and combined, in canine Purkinje fibers.J Cardiovasc Pharmacol. 1988 Sep;12(3):286-92. doi: 10.1097/00005344-198809000-00005. J Cardiovasc Pharmacol. 1988. PMID: 2464100
-
Pharmacology, electrophysiology, and pharmacokinetics of mexiletine.Am Heart J. 1984 May;107(5 Pt 2):1058-65. doi: 10.1016/0002-8703(84)90175-3. Am Heart J. 1984. PMID: 6326558 Review.
Cited by
-
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.Drugs. 1993 Oct;46(4):678-719. doi: 10.2165/00003495-199346040-00007. Drugs. 1993. PMID: 7506652 Review.